Results 11 to 20 of about 1,676 (161)

Refractory Pemphigoid with Autoantibodies to Both BP230 and Laminin gamma1

Acta Dermato-Venereologica, 2019
is missing (Short communication)
Himino Ashida, Toshihisa Hamada, Yoichiro Hosokawa, Takashi Hashimoto, Wataru Nishie, Norito Ishii, Takekuni Nakama, Taisuke Kanno, Masami Ikeda   +8 more
doaj   +4 more sources

Sita- and saxagliptin use and autoantibodies to autoimmune bullous diseases: A cross-sectional study. [PDF]

J Eur Acad Dermatol Venereol
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 4, Page e227-e230, April 2026.
Dräger S, Kauderer C, Meyhöfer S, Dräger L, Marquardt JU, Ludwig RJ, Arndt S, Boch K, Bieber K.   +8 more
europepmc   +2 more sources

Antibodies to Laminin β4 in Pemphigoid Diseases: Clinical–Laboratory Experience of a Single Central European Reference Centre [PDF]

Antibodies
Background/Objectives: Anti-p200 pemphigoid is a rare and likely underdiagnosed autoimmune blistering disorder. Laminin γ1 and laminin β4 have been implicated as potential target antigens in its pathogenesis. Recently, a novel indirect immunofluorescence
Maciej Marek Spałek, Magdalena Jałowska, Natalia Welc, Monika Bowszyc-Dmochowska, Takashi Hashimoto, Justyna Gornowicz-Porowska, Marian Dmochowski   +6 more
doaj   +2 more sources

Adjuvante Therapie des schweren und/oder refraktären bullösen Pemphigoids mit Immunadsorption – eine prospektive monozentrische Pilotstudie [PDF]

J Dtsch Dermatol Ges
Zusammenfassung Hintergrund und Zielsetzung Das bullöse Pemphigoid (BP) ist die häufigste blasenbildende Autoimmunerkrankung in der westlichen Welt. Während die Mehrheit der Patienten mit BP durch die langfristige Anwendung von Kortikosteroiden mit oder ohne Immunmodulatoren/Immunsuppressiva Remissionen erreicht, empfehlen nationale und internationale ...
Holtsche M, van Beek N, Hammers C, Vorobyev A, Kasperkiewicz M, Schumacher N, Muck P, Schmidt E.   +7 more
europepmc   +2 more sources

Apport d’une sismique en ondes S pour la recherche hydrogéologique dans un aquifère alluvial [PDF]

E3S Web of Conferences, 2022
Dans le cadre de l’implantation de nouveaux forages en contexte de plaine alluvial dans le Bassin de Paris, une nouvelle méthode géophysique a été mise en œuvre afin d’imager proprement les alluvions et d’en préciser les séquences ainsi que leur ...
Miquelis Florian, Hanot Franck, Gravelat Serge, Lafont Audrey   +3 more
doaj   +1 more source

Coexistence of bullous pemphigoid with neuropsychiatric comorbidities is associated with anti‐BP230 seropositivity [PDF]

Journal of the European Academy of Dermatology and Venereology, 2021
AbstractBackgroundWhile clustering of bullous pemphigoid (BP) with neuropsychiatric diseases is well‐established, the clinical and immunological profile of BP patients with this comorbidity remains to be decisively determined.ObjectivesTo evaluate the burden of neurological and psychiatric comorbidities among patients with BP and to elucidate the ...
S. Ständer, C.M. Hammers, A. Vorobyev, E. Schmidt, J.E. Hundt, C.D. Sadik, T. Lange, D. Zillikens, R.J. Ludwig, K. Kridin   +9 more
openaire   +2 more sources

Current approaches to the diagnosis of autoimmune bullous dermatoses

Vestnik Dermatologii i Venerologii, 2021
A modern review of highly effective methods for the diagnosis of autoimmune bullous dermatoses are presented. The specificity of the production of autoantibodies underlying bullous dermatoses are described.
Marianna B. Drozhdina, Varvara A. Bobro, Yuliana A. Sennikova   +2 more
doaj   +1 more source

Case report: Bullous pemphigoid arising in a patient with scleroderma and multiple sclerosis

Frontiers in Medicine, 2022
BackgroundBullous pemphigoid (BP) is the most common autoimmune-blistering disease, clinically characterized by erythematous urticarial plaques, blisters, and intense pruritus, induced by autoantibodies against two proteins of the dermo-epidermal ...
Francesco Moro, Francesco Moro, Feliciana Mariotti, Anna Pira, Naomi De Luca, Biagio Didona, Gianluca Pagnanelli, Giovanni Di Zenzo   +7 more
doaj   +1 more source

Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study

Frontiers in Medicine, 2022
Bullous pemphigoid (BP) is an autoimmune bullous disease caused by circulating autoantibodies toward the hemidesmosomal antigens BP180 and BP230. Cases of BP have been described following vaccinations against tetanus, poliomyelitis, diphtheria, influenza,
Carlo Alberto Maronese, Carlo Alberto Maronese, Marzia Caproni, Chiara Moltrasio, Chiara Moltrasio, Giovanni Genovese, Giovanni Genovese, Pamela Vezzoli, Paolo Sena, Giulia Previtali, Emanuele Cozzani, Giulia Gasparini, Aurora Parodi, Laura Atzori, Emiliano Antiga, Roberto Maglie, Francesco Moro, Elena Biancamaria Mariotti, Alberto Corrà, Sabatino Pallotta, Biagio Didona, Angelo Valerio Marzano, Angelo Valerio Marzano, Giovanni Di Zenzo   +23 more
doaj   +1 more source

Risk Factors for Mucosal Involvement in Bullous Pemphigoid and the Possible Mechanism: A Review

Frontiers in Medicine, 2021
Bullous pemphigoid (BP) is the most common type of autoimmune bullous disease and is characterized by the presence of circulating anti-BP180 and/or anti-BP230 autoantibodies.
Xinyi Chen, Wenlin Zhao, Hongzhong Jin, Li Li   +3 more
doaj   +1 more source